{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Back Bay Life Science Report","title":"Preparing BioPharma and Medtech Companies for Public Listing - Back Bay Life Science Advisors and Nasdaq Nordic","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/22be8516\"></iframe>","width":"100%","height":180,"duration":1681,"description":"The Nordic Nasdaq system—specifically the Stockholm markets—recently unveiled access to US biopharma and medtech companies to list on the Stockholm Exchange, either primarily or as a dual listing.\r\n\r\nIn this episode Jonathan Gertler and Maria Groschopp Dellwik of Nasdaq talk through how this recent policy shift could change the game for Nordic and US companies and their best practices for companies preparing to go public.","thumbnail_url":"https://img.transistorcdn.com/W6Lngt-BhnFN8FVt3HSPeq-NUJHgo4jaJncMb2aU6_E/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81NjE3/MTc3NDg3NzgyNTI0/ODE3Y2ViM2Q4OWI5/MDUzMC5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}